Biotinoyl Tripeptide-1

Hair / Growth

Also known as: Biotinyl-GHK, Procapil Component

Signal Peptides (Cosmetic)Research phase: In-vitro studies, clinical cosmetic trialsRegulatory: Not a drug — cosmetic ingredient (INCI registered). Sederma proprietary (Procapil).

Mechanism

A biotin-linked version of the well-known GHK peptide, designed specifically for hair health. It strengthens the anchor between the hair follicle and the scalp (dermal papilla), improves nutrient delivery to follicles, and slows follicle aging. It's a key ingredient in Procapil, a popular hair growth complex combined with apigenin and oleanolic acid.

Technical detail

Biotin (vitamin B7) conjugated to the tripeptide GHK (Gly-His-Lys). Biotin moiety provides direct nutritional support to follicular keratinocytes (cofactor for carboxylases in fatty acid synthesis and amino acid metabolism). GHK portion activates dermal papilla cells: upregulates VEGF (improved follicular vascularization), stimulates decorin and glycosaminoglycan synthesis (strengthens follicle anchoring), and chelates copper (antioxidant, enzyme cofactor). Component of Procapil (Sederma): combined with apigenin (anti-inflammatory, reduces perifollicular fibrosis) and oleanolic acid (5-alpha reductase inhibitor). Clinical data: 121% improvement in anagen/telogen ratio.

Effects

## Integumentary/Hair Follicle System [Tier 2 - In Vitro/Small Human Studies] - Tripeptide conjugated with biotin (vitamin B7) for enhanced follicular penetration and metabolic support - Part of the Procapil complex (biotinoyl-tripeptide-1 + apigenin + oleanolic acid) - Strengthens the anchoring of hair shaft within the follicle by reinforcing ECM proteins at the dermal-epidermal junction - Reduces follicular aging by improving metabolic activity of the dermal papilla through biotin-dependent carboxylase activation - Increases hair tensile strength and resistance to breakage ## Dermal Papilla/Metabolism [Tier 2 - In Vitro] - Biotin moiety supports energy metabolism in follicular cells (biotin is a cofactor for carboxylases in fatty acid synthesis and gluconeogenesis) - Tripeptide component stimulates collagen III and collagen VII production in the dermal-epidermal junction (anchoring fibrils) - Improved anchoring reduces anagen-phase hair loss (non-scarring alopecia from weak anchoring) ## Anti-Androgen/Follicular [Tier 3 - In Vitro] - As part of Procapil: apigenin provides anti-inflammatory action, oleanolic acid inhibits 5-alpha-reductase - The tripeptide component itself does not have strong anti-DHT activity — that role is filled by the other Procapil components - Combined Procapil complex addresses: anchoring (peptide), inflammation (apigenin), DHT (oleanolic acid) ## Vascular/Circulatory [Tier 3 - Mechanistic] - Improved dermal papilla metabolism may enhance local microcirculation demand signaling - Does not directly promote angiogenesis (unlike AHK-Cu)

Practitioner Guide

## Clinical Positioning Biotinoyl-tripeptide-1 is the peptide component of Procapil, a hair loss cosmeceutical ingredient developed by Sederma. Like Capixyl, it is a TOPICAL ingredient. Its primary mechanism is strengthening hair anchoring — it helps hair STAY in the follicle rather than being shed prematurely. It is the "anti-shedding" peptide. ## Formulation Guide ### Concentration - Procapil complex: typically 1-3% in finished formulations - Biotinoyl-tripeptide-1 alone: 50-200 ppm in topical solutions - Most commercial products use the complete Procapil complex rather than the isolated peptide ### Topical Serum Formulation Compatible ingredients: - All other hair peptides (acetyl-tetrapeptide-3, AHK-Cu, myristoyl-pentapeptide-17) - Niacinamide, panthenol, biotin, caffeine - Glycerin, propanediol, hyaluronic acid Simple formulation: - Procapil complex: 3% - Capixyl complex: 5% - Caffeine: 1% (additional follicle stimulant) - Panthenol: 2% - Phenoxyethanol: 0.8% - Purified water: QS to 100% Application: 1mL to scalp daily, preferably PM. ### Where It Fits in a Comprehensive Protocol Think of the hair peptides as a team: - AHK-Cu: stimulates follicle growth and blood supply - Acetyl-tetrapeptide-3: blocks DHT and supports ECM - Biotinoyl-tripeptide-1 (Procapil): anchors hair and supports follicle metabolism - Myristoyl-pentapeptide-17: boosts keratin production for shaft thickness All four address different aspects of hair loss. Combining them in one serum covers multiple mechanisms. ### Combining with Minoxidil/Finasteride - Fully compatible as an adjunct to minoxidil and/or finasteride - Particularly useful for patients on minoxidil who still have excessive shedding (the anchoring support helps) - Women who cannot take finasteride benefit from the topical peptide approach ## Realistic Expectations - Month 1-2: reduced hair shedding (most noticeable benefit) - Month 2-4: existing hairs feel stronger, less breakage during styling - Month 4-6: modest improvement in hair density from reduced loss + new growth - Best results when used in combination with other active ingredients - As monotherapy: mild improvement only — primarily anti-shedding rather than regrowth

Research Summary

## Tier 1 — Limited Human Data - Manufacturer clinical study (Sederma): Procapil applied for 4 months showed 46% reduction in hair loss (telogen count) and improved anagen/telogen ratio - Small independent studies (10-30 subjects) confirm reduced shedding with Procapil use - No large-scale, independent, peer-reviewed RCTs ## Tier 2 — In Vitro Data - Follicular keratinocyte cultures: biotinoyl-tripeptide-1 increased adhesion molecule expression and collagen VII production - Hair follicle organ culture: reduced premature catagen entry and improved hair shaft anchorage force - Biotin-conjugated peptides show improved follicular uptake vs. non-conjugated forms ## Tier 3 — Mechanistic - Biotin conjugation exploits biotin transport mechanisms (SMVT transporter) present on keratinocytes for enhanced cellular uptake - Tripeptide fragment stimulates ECM production through integrin-mediated signaling - Biotin as cofactor supports acetyl-CoA carboxylase and propionyl-CoA carboxylase in follicular cell metabolism ## Evidence Gaps - Isolated biotinoyl-tripeptide-1 (without Procapil co-ingredients) not studied independently in humans - Dose-response characterization absent - Comparison with oral biotin supplementation for hair not studied - Long-term efficacy data beyond 6 months not available